A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Gene Therapy

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cgt.7700620PMID 12944987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of immune stimulation by bacterial DNA

  2009cited by this paper
• CpG motifs in bacterial DNA and their immune effects.

  2002cited by this paper
• A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.

  2002influential reference
• A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.

  2002cited by this paper
• Xenogeneic DNA immunization in melanoma models for minimal residual disease.

  2002cited by this paper
• Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.

  2002cited by this paper
• Elicitation of High-Frequency Cytotoxic T-Lymphocyte Responses against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys

  2001cited by this paper
• Th1 genetic adjuvants modulate immune responses in neonates.

  2001influential reference
• Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.

  2001cited by this paper
• Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

  2000cited by this paper
• Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

  2000cited by this paper
• Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

  2000cited by this paper
• Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.

  2000cited by this paper
• Effect of transforming growth factor-beta1 on microglial MHC-class II expression.

  2000influential reference
• Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells.

  2000cited by this paper
• Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma

  2000cited by this paper
• Effect of transforming growth factor-β1 on microglial MHC-class II expression

  2000cited by this paper
• Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.

  1999cited by this paper
• The cell biology of the blood-brain barrier.

  1999cited by this paper
• Opposite effects of interferon‐γ and prostaglandin E2 on tumor necrosis factor and interleukin‐10 production in microglia: A regulatory loop controlling microglia pro‐ and anti‐inflammatory activities

  1999cited by this paper
• Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

  1999cited by this paper
• Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes.

  1999cited by this paper
• Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

  1999cited by this paper
• Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.

  1999cited by this paper
• Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.

  1998cited by this paper
• Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

  1998cited by this paper
• Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).

  1998cited by this paper
• HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.

  1998cited by this paper
• Antigen Presentation in the Central Nervous System

  1998cited by this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cited by this paper
• Immunotherapy of cancer with dendritic cell-based vaccines

  1998cited by this paper
• IL‐10 down‐regulates T cell activation by antigen‐presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules

  1998cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Immunotherapy of cancer with dendritic-cell-based vaccines

  1998cited by this paper
• Efficient Retrovirus‐mediated Cytokine‐gene Transduction of Primary‐cultured Human Glioma Cells for Tumor Vaccination Therapy

  1997cited by this paper
• Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

  1997cited by this paper
• Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.

  1996cited by this paper
• The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.

  1995cited by this paper
• Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.

  1995cited by this paper
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

  1995cited by this paper
• Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid.

  1994cited by this paper
• Preferential but not exclusive T cell receptor V beta chain utilization of myelin basic protein and peptide-specific T cell clones in mice.

  1994cited by this paper
• Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis.

  1994cited by this paper
• Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2.

  1994cited by this paper
• Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed.

  1994cited by this paper
• Transforming growth factor‐β2 induces apoptosis of murine T cell clones without down‐regulating bcl‐2 mRNA expression

  1994cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?

  1991cited by this paper
• Viral persistence in neurons explained by lack of major histocompatibility class I expression.

  1991cited by this paper
• Immunology of central nervous system tumors.

  1989cited by this paper
• Immunologie des tumeurs du système nerveux central

  1989cited by this paper
• [Immunology of tumors of the central nervous system].

  1989cited by this paper
• National survey of patterns of care for brain-tumor patients.

  1989cited by this paper
• Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

  1982cited by this paper

• Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients.

  2024cites this paper
• Nucleic acid immunotherapeutics and vaccines: a promising approach to glioblastoma multiforme treatment.

  2023cites this paper
• Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice.

  2023cites this paper
• Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model

  2022cites this paper
• Transcriptional analysis of differential immune responses to Sarcoptes scabiei infestation in a porcine model.

  2018cites this paper
• Combating Established Mouse Glioblastoma through Nicotinylated‐Liposomes‐Mediated Targeted Chemotherapy in Combination with Dendritic‐Cell‐Based Genetic Immunization

  2017cites this paper
• The Multiple Roles of Tyrosinase-Related Protein-2/L- Dopachrome Tautomerase in Melanoma: Biomarker, Therapeutic Target, and Molecular Driver in Tumor Progression

  2017cites this paper
• DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.

  2016cites this paper
• Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• In vivo visualization of GL261-luc2 mouse glioma cells by use of Alexa Fluor-labeled TRP-2 antibodies.

  2014cites this paper
• Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma

  2014cites this paper
• Innovative DNA Vaccine to Break Immune Tolerance Against Tumor Self-Antigen

  2013cites this paper
• Downregulation of KIF23 suppresses glioma proliferation

  2012cites this paper
• Incomplete tumour control following DNA vaccination against rat gliomas expressing a model antigen

  2012cites this paper
• Immunotherapy for Glioblastoma

  2010cites this paper
• CD4+ and CD8+ T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/neu Virus-Like Particles

  2010cites this paper
• Tumor-DNA Based Vaccines Fail to Induce Autoimmune Disease in Mice

  2010cites this paper
• Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen

  2010cites this paper
• the Target Antigen Damaging the Brain despite Sharing Intracranial Tumor Cells without Immunotherapy Can Reject

  2010cites this paper
• Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression

  2009cites this paper
• In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma

  2008cites this paper
• Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate‐pulsed dendritic cells in a murine glioma model

  2007cites this paper
• DNA vaccines for cancer too

  2006cites this paper
• Identifikation von Antigenen eines großzelligen Medulloblastoms mittels der autologen serologischen Analyse einer Tumor cDNA-Expressionsbibliothek (SEREX)

  2006cites this paper
• Central Nervous System Tumor Immunity Generated by a Recombinant Listeria monocytogenes Vaccine Targeting Tyrosinase Related Protein-2 and Real-Time Imaging of Intracranial Tumor Burden

  2006cites this paper
• Identification of a glioma antigen, GARC‐1, using cytotoxic T lymphocytes induced by HSV cancer vaccine

  2006cites this paper
• The Role of DCT/TYRP2 in Resistance of Melanoma Cells to Drugs and Radiation

  2006cites this paper
• Detection of Spontaneous CD4+ T-Cell Responses in Melanoma Patients against a Tyrosinase-Related Protein-2–Derived Epitope Identified in HLA-DRB1*0301 Transgenic Mice

  2005cites this paper
• ‘Survival gene’ Bcl-xl potentiates DNA-raised antitumor immunity

  2005cites this paper
• AIM-2: A Novel Tumor Antigen is Expressed and Presented by Human Glioma Cells

  2004cites this paper
• DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins

  2004cites this paper
• despite Sharing the Target Antigen Tumor Cells without Damaging the Brain Immunotherapy Can Reject Intracranial

  year unknowncites this paper